Drug Trial Radar · NCT06330038
Anesthesia and Non-small Cell Lung Cancer Recurrence
Last checked: Nov 19, 2026Latest source record: Apr 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5,384
Planned (sponsor's estimate)
Start
Aug 5, 2024
Primary completion
Dec 31, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Samsung Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Seoul National University Hospital; Asan Medical Center; Severance Hospital; Seoul St. Mary's Hospital; Korea University Guro Hospital; DongGuk University; Inha University Hospital; Konkuk University Medical Center; Ewha Womans University; Chungnam National University Hospital; University of Virginia; Memorial Sloan Kettering Cancer Center; Yale University; Mayo Clinic; University of Texas Southwestern Medical Center; University Hospitals Coventry and Warwickshire NHS Trust; Khon Kaen University; King Chulalongkorn Memorial Hospital; The Affiliated Hospital of Qingdao University; Beijing Hospital; All India Institute of Medical Sciences
- First posted
- Mar 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
There has been ongoing debate about the relationship between cancer recurrence and anesthetic management. Therefore, the investigators will test the hypothesis that the recurrence free survival (RFS) after curative resection of NSCLC is higher in patient who received total intravenous anesthesia (TIVA) than volatile anesthetics in this multi-center randomized trials.
Conditions
- Non-small Cell Lung Cancer
- Surgery
- Anesthesia
Interventions
PropofolDrug
Propofol will be used for the induction and maintenance of general anesthesia.
Inhaled anestheticsDrug
Inhaled anesthetics will be used for the maintenance of general anesthesia.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Recurrence free survivalTime frame: Within 3 year after curative resection for NSCLC
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Samsung Medical Center
Seoul, Seoul-teukbyeolsi, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.